source Post navigation Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis – Cardiovascular Diabetology ‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes – Cardiovascular Business